Free Trial

CeriBell (CBLL) Competitors

CeriBell logo
$15.38 -0.37 (-2.35%)
As of 12:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CBLL vs. EYE, LMAT, NVCR, SSII, ENOV, CNMD, CDRE, AORT, LQDA, and ESTA

Should you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include National Vision (EYE), LeMaitre Vascular (LMAT), NovoCure (NVCR), SS Innovations International (SSII), Enovis (ENOV), CONMED (CNMD), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

CeriBell vs. Its Competitors

National Vision (NASDAQ:EYE) and CeriBell (NASDAQ:CBLL) are both medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

CeriBell has a net margin of 0.00% compared to National Vision's net margin of -1.40%. National Vision's return on equity of 3.44% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-1.40% 3.44% 1.40%
CeriBell N/A N/A N/A

National Vision has higher revenue and earnings than CeriBell.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B1.10-$28.50M-$0.33-76.83
CeriBell$65.44M8.48-$40.46MN/AN/A

In the previous week, National Vision had 7 more articles in the media than CeriBell. MarketBeat recorded 8 mentions for National Vision and 1 mentions for CeriBell. National Vision's average media sentiment score of 1.02 beat CeriBell's score of 0.00 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
4 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
CeriBell
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision presently has a consensus target price of $23.00, indicating a potential downside of 9.29%. CeriBell has a consensus target price of $32.14, indicating a potential upside of 109.33%. Given CeriBell's stronger consensus rating and higher possible upside, analysts clearly believe CeriBell is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
CeriBell
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

National Vision beats CeriBell on 6 of the 11 factors compared between the two stocks.

Get CeriBell News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBLL vs. The Competition

MetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$554.93M$10.36B$5.68B$9.50B
Dividend YieldN/A2.03%4.05%3.99%
P/E RatioN/A17.3227.9520.00
Price / Sales8.4827.51397.1083.19
Price / CashN/A22.6936.1958.45
Price / Book2.883.718.665.83
Net Income-$40.46M$234.77M$3.24B$258.39M
7 Day Performance-1.70%5.20%3.33%2.30%
1 Month Performance-21.86%8.61%10.84%12.42%
1 Year PerformanceN/A-1.64%35.32%21.16%

CeriBell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CBLL
CeriBell
2.0539 of 5 stars
$15.36
-2.5%
$32.14
+109.3%
N/A$554.93M$65.44M0.00N/A
EYE
National Vision
2.8195 of 5 stars
$25.31
+0.9%
$22.10
-12.7%
+91.6%$1.98B$1.82B-76.6913,411Positive News
Analyst Forecast
LMAT
LeMaitre Vascular
2.7093 of 5 stars
$79.82
+0.1%
$97.83
+22.6%
-8.8%$1.80B$219.86M40.31490Analyst Forecast
NVCR
NovoCure
3.7055 of 5 stars
$16.10
+0.5%
$32.43
+101.4%
-12.0%$1.79B$605.22M-10.661,488News Coverage
Earnings Report
SSII
SS Innovations International
N/A$8.40
+5.9%
N/AN/A$1.54B$20.65M0.004Gap Up
ENOV
Enovis
2.9345 of 5 stars
$26.35
+0.2%
$55.60
+111.0%
-39.8%$1.50B$2.11B-1.897,367High Trading Volume
CNMD
CONMED
4.7569 of 5 stars
$47.78
+0.3%
$62.20
+30.2%
-31.5%$1.47B$1.31B12.573,900Upcoming Earnings
CDRE
Cadre
3.3772 of 5 stars
$32.27
-1.1%
$37.50
+16.2%
-12.3%$1.33B$567.56M33.962,284Positive News
Dividend Announcement
AORT
Artivion
2.9199 of 5 stars
$30.63
+0.5%
$32.40
+5.8%
+11.8%$1.30B$388.54M-61.261,600News Coverage
LQDA
Liquidia Technologies
3.1787 of 5 stars
$15.10
+3.9%
$26.89
+78.1%
+53.7%$1.24B$14M-9.5650News Coverage
ESTA
Establishment Labs
2.0619 of 5 stars
$42.60
+2.5%
$54.83
+28.7%
-10.1%$1.20B$166.02M-13.741,018Positive News

Related Companies and Tools


This page (NASDAQ:CBLL) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners